-
Santhera Joins Swiss Researchers to Develop LAMA2 MD Gene Therapy
Santhera Pharmaceuticals is collaborating with researchers from the University of Basel to develop a new gene therapy for treating people with LAMA2 MD. Read more about the partnership here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.